Justin Beltz

Justin Beltz

Auto-generated profile, based on publicly available information

Justin Beltz

Department of Chemistry, Missouri University of Science & Technology, Rolla, MO, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2020 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
APAnnalise Pfaff
Annalise Pfaff
JBJustin Beltz
Justin Beltz
EKEmily King
Emily King
NENuran Ercal
Nuran Ercal
The thiol (-SH) functional group is found in a number of drug compounds and confers a unique combination of useful properties. Thiol-containing drugs can reduce radicals and other toxic electrophiles, restore cellular thiol pools, and form stable complexes with heavy metals such as lead, arsenic, and copper. Thus, thiols can treat a variety of conditions by serving as radical scavengers, GSH prodrugs, or metal chelators. Many of the compounds discussed here have been in use for decades, yet continued exploration of their properties has yielded new understanding in recent years, which can be used to optimize their clinical application and provide insights into the development of new treatments. The purpose of this narrative review is to highlight the biochemistry of currently used thiol drugs within the context of developments reported in the last five years. More specifically, this review focuses on thiol drugs that represent the standard of care for their associated conditions, including N-acetylcysteine, 2,3-meso-dimercaptosuccinic acid, British anti-Lewisite, D-penicillamine, amifostine, and others. Reports of novel dosing regimens, delivery strategies, and clinical applications for these compounds were examined with an eye toward emerging approaches to address a wide range of medical conditions in the future.

22 May 2020 in Free Radical Research
Verified
Journal Article
Closed access
JBJustin Beltz
Justin Beltz
ACAnna Chernatynskaya
Anna Chernatynskaya
APAnnalise Pfaff
Annalise Pfaff
NENuran Ercal
Nuran Ercal
Tiopronin (MPG) is a thiol antioxidant drug that has been explored as a treatment for various oxidative stress-related disorders. However, many of its antioxidant capabilities remain untested in well-validated cell models. To more thoroughly understand the action of this promising pharmaceutical compound against acute oxidative challenge, A549 human lung carcinoma cells were exposed to tert-butyl hydroperoxide (tBHP) and treated with MPG. Analyses of cell viability, intracellular glutathione (GSH) levels, and prevalence of reactive oxygen species (ROS) and mitochondrial superoxide were used to examine the effects of MPG on tBHP-challenged cells. MPG treatment suppressed intracellular ROS and mitochondrial superoxide and prevented tBHP-induced GSH depletion and apoptosis. These results indicate that MPG is effective at preserving redox homeostasis against acute oxidative insult in A549 cells if present at sufficient concentrations during exposure to oxidants such as tBHP. The effects of treatment gleaned from this study can inform experimental design for future in vivo work on the therapeutic potential of MPG.

3 September 2018 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
JBJustin Beltz
Justin Beltz
APAnnalise Pfaff
Annalise Pfaff
NENuran Ercal
Nuran Ercal